Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

BACKGROUND: Previous studies comparing insulin degludec/insulin aspart (IDegAsp) with premixed insulin twice daily among insulin users with type 2 diabetes have not thoroughly investigated differences in the glucose variability and psychological evaluations related to insulin regimen changes. We inv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetol Metab Syndr
Main Authors: Fujimoto, Kanta, Iwakura, Toshio, Aburaya, Megumi, Matsuoka, Naoki
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097398/
https://ncbi.nlm.nih.gov/pubmed/30127860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-018-0366-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares